{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT03645460",
      "OrgStudyIdInfo": {
        "OrgStudyId": "GIMI-IRB-18003"
      },
      "Organization": {
        "OrgFullName": "Shenzhen Geno-Immune Medical Institute",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Gene Transfer for ADA-SCID Using an Improved Lentiviral Vector (TYF-ADA)",
      "OfficialTitle": "Gene Transfer for Adenosine Deaminase-severe Combined Immunodeficiency (ADA-SCID) Using an Improved Self-inactivating Lentiviral Vector (TYF-ADA)"
    },
    "StatusModule": {
      "StatusVerifiedDate": "September 2019",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "October 30, 2018",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "December 31, 2020",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 31, 2021",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "July 17, 2018",
      "StudyFirstSubmitQCDate": "August 22, 2018",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "August 24, 2018",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "September 18, 2019",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "September 20, 2019",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Shenzhen Geno-Immune Medical Institute",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "Gene transfer for ADA-SCID using an improved lentiviral vector (TYF-ADA)",
      "DetailedDescription": "This clinical trial will evaluate a safety and efficiency improved lentiviral vector system for delivering a therapeutic gene to patients with severe combined immunodeficiency (SCID) due to a defective adenosine deaminase (ADA) gene. This gene encodes for the adenosine deaminase enzyme, which is essential for the proper growth and function of infection-fighting white blood cells called T and B lymphocytes. Patients who lack this enzyme are vulnerable to frequent and severe infections.\n\nADA-SCID patients are normally rescued by a bone marrow transplant (BMT) from a matched healthy donor. However, matched donors are difficult to find and donor BMT is associated with high risk. This trial aims to treat ADA-SCID using a safety and efficiency improved self-inactivating lentiviral vector carrying a functional ADA gene to correct the genetic defect. By collecting an individual's stem cells and modifying them with a lentivirus, the gene-corrected cells can be returned to the patient to help produce normal healthy immune cells.The primary objectives are to evaluate the safety of the improved self-inactivating lentiviral vector TYF-ADA, the ex vivo gene transfer clinical protocol and the efficacy of immune reconstitution in patients overcoming frequent infections present at the time of treatment. We will assess the lentiviral gene integration sites and the long-term effect of this gene transfer procedure."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Adenosine DeAminase Severe Combined ImmunoDeficiency (ADA-SCID)"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Adenosine deaminase severe combined immunodeficiency lentiviral vector"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Not Applicable"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "10",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "TYF-ADA-modified autologous stem cells",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Autologous hematopoietic and/or mesenchymal stem cells transduced with lentiviral vector carrying the ADA gene",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Genetic: TYF-ADA gene-modified autologous stem cells"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Genetic",
            "InterventionName": "TYF-ADA gene-modified autologous stem cells",
            "InterventionDescription": "Infusion of TYF-ADA-modified autologous stem cells at 1~10x10^6 gene-modified cells per kg body weight; or more infusions depending on the circumstances",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "TYF-ADA-modified autologous stem cells"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Overall survival up to a year",
            "PrimaryOutcomeDescription": "Patient will be monitored for overall health condition, including immune cell assessments, blood biochemistry and metabolitic activities, metabolic detoxification, gene-modified cell percentage and vector copy number (VCN) in the blood, and continued follow-up for 15 years.",
            "PrimaryOutcomeTimeFrame": "15 years"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "1. Success of immune reconstitution",
            "SecondaryOutcomeDescription": "Immunological and metabolic values including all leukocyte counts (ALC), T, B and NK cell counts (CD3, CD4, CD8, CD19, CD56), T cell TREC levels, T cell repertoire diversity, PHA proliferation rate, immunoglobulins and dATP levels will be measured.",
            "SecondaryOutcomeTimeFrame": "12 month"
          },
          {
            "SecondaryOutcomeMeasure": "2. Change of infection status",
            "SecondaryOutcomeDescription": "Immune recovery associated with reduction of infection episodes and frequencies, including viral, fungal and bacterial infections will be documented.",
            "SecondaryOutcomeTimeFrame": "12 month"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nDiagnosis of classical ADA-SCID based on:\n\nA proven defective adenosine deaminase (ADA) gene as defined by direct sequencing of patient DNA.\nT-cell immune deficiency defined as one or more of the following: CD3+ autologous T cells < 300/ul, or less than 50% of normal value for in vitro mitogen stimulation, or absent proliferation in vitro to antigens.\nWith severe infections, including but not limited to: pneumonitis; protracted diarrhea requiring total parenteral nutrition; infection with herpes viruses or adenovirus or fungus; disseminated BCG infection.\nNo cytogenetic abnormalities (medullary karyotype) and no detection of main rearrangements associated with acute leukemia of children.\nNo prior allogeneic stem cell transplantation.\nLife expectancy â‰¥ 2 months.\nNegative for HIV infection.\nWritten, informed consent obtained prior to any study-specific procedures.\n\nExclusion Criteria:\n\nNone",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "1 Month",
      "StdAgeList": {
        "StdAge": [
          "Child",
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Lung-Ji Chang, Ph.D",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "86-0755-86725195",
            "CentralContactEMail": "c@szgimi.org"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Lung-Ji Chang, Ph.D",
            "OverallOfficialAffiliation": "Shenzhen Geno-Immune Medical Institute",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Shenzhen Geno-immune Medical Institute",
            "LocationStatus": "Recruiting",
            "LocationCity": "Shenzhen",
            "LocationState": "Guangdong",
            "LocationZip": "518000",
            "LocationCountry": "China",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Lung-Ji Chang, Ph.D",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "86-0755-86725195",
                  "LocationContactEMail": "c@szgimi.org"
                },
                {
                  "LocationContactName": "XiaoDong Shi, M.D./P.H.D",
                  "LocationContactRole": "Principal Investigator"
                },
                {
                  "LocationContactName": "Jie Zheng, M.D./P.H.D",
                  "LocationContactRole": "Principal Investigator"
                }
              ]
            }
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000016511",
            "ConditionMeshTerm": "Severe Combined Immunodeficiency"
          },
          {
            "ConditionMeshId": "D000007153",
            "ConditionMeshTerm": "Immunologic Deficiency Syndromes"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000007154",
            "ConditionAncestorTerm": "Immune System Diseases"
          },
          {
            "ConditionAncestorId": "D000081207",
            "ConditionAncestorTerm": "Primary Immunodeficiency Diseases"
          },
          {
            "ConditionAncestorId": "D000030342",
            "ConditionAncestorTerm": "Genetic Diseases, Inborn"
          },
          {
            "ConditionAncestorId": "D000007232",
            "ConditionAncestorTerm": "Infant, Newborn, Diseases"
          },
          {
            "ConditionAncestorId": "D000049914",
            "ConditionAncestorTerm": "DNA Repair-Deficiency Disorders"
          },
          {
            "ConditionAncestorId": "D000008659",
            "ConditionAncestorTerm": "Metabolic Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M9351",
            "ConditionBrowseLeafName": "Immunologic Deficiency Syndromes",
            "ConditionBrowseLeafAsFound": "Immunodeficiency",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M18060",
            "ConditionBrowseLeafName": "Severe Combined Immunodeficiency",
            "ConditionBrowseLeafAsFound": "Severe Combined Immunodeficiency",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M15507",
            "ConditionBrowseLeafName": "Syndrome",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9352",
            "ConditionBrowseLeafName": "Immune System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M2286",
            "ConditionBrowseLeafName": "Primary Immunodeficiency Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M22839",
            "ConditionBrowseLeafName": "Genetic Diseases, Inborn",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9428",
            "ConditionBrowseLeafName": "Infant, Newborn, Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M25284",
            "ConditionBrowseLeafName": "DNA Repair-Deficiency Disorders",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M10791",
            "ConditionBrowseLeafName": "Metabolic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T5187",
            "ConditionBrowseLeafName": "Severe Combined Immunodeficiency",
            "ConditionBrowseLeafAsFound": "Severe Combined Immunodeficiency",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "T205",
            "ConditionBrowseLeafName": "Adenosine Deaminase Deficiency",
            "ConditionBrowseLeafAsFound": "ADA-SCID",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC20",
            "ConditionBrowseBranchName": "Immune System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC16",
            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC18",
            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M2747",
            "InterventionBrowseLeafName": "Adenosine",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "AnArAg",
            "InterventionBrowseBranchName": "Anti-Arrhythmia Agents"
          },
          {
            "InterventionBrowseBranchAbbrev": "VaDiAg",
            "InterventionBrowseBranchName": "Vasodilator Agents"
          },
          {
            "InterventionBrowseBranchAbbrev": "Analg",
            "InterventionBrowseBranchName": "Analgesics"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}